2026-10-02 → 10-15 Capital
Medtronic Completes MiniMed Separation, MiniMed Lists Independently Separation completed, both entities operate independently; earlier exchange offer was oversubscribed.
D1 -0.1% · +5d +2.4%
› 3 waves of this story2026-10-02 Barron's reports tax-free split-off offer losing appeal to investors2026-10-13 Offer expired at max exchange ratio; MMED shares expected this week2026-10-15 Separation completed, both entities operate independently; earlier exchange offer was oversubscribed.2026-09-09 → 09-23 Company Bull
Medtronic beats Q1, raises FY27 guidance to 7.25%-7.75% Multiple analysts confirm ~7% organic growth; new businesses like Cardiac Ablation add momentum
D1 -0.5% · +5d +0.8%
› 2 waves of this story2026-09-09 Company lifts guidance, cites AI/robotics/ablation growth; margin pressure and competition remain challenges2026-09-23 Multiple analysts confirm ~7% organic growth; new businesses like Cardiac Ablation add momentum16 earlier events › 2026-09-18 8-K filing
8-K: Item 8.01, Item 9.01 D1 -0.7% · +5d -3.8%
2026-09-16 Product Bull
Medtronic's LigaSure Receives FDA Clearance for Hugo RAS FDA clearance expands robotic surgery applications, strengthening product portfolio
D1 -1.2% · +5d -3.6%
2026-09-14 Capital
Medtronic Launches Exchange Offer to Complete MiniMed Separation Shareholders can exchange shares; separation advances as MiniMed files S-4
D1 +3.1% · +5d -2.2%
2026-08-28 → 09-04 Earnings Bull
Medtronic Beats Q1 Estimates, Raises Guidance; Analysts Lift Forecasts Strongest revenue growth in a decade, driven by cardiovascular business
D1 +1.4% · +5d +3.2%
› 4 waves of this story2026-08-28 Multiple sources confirm earnings date; analysts project EPS $1.39 and revenue $9.47B2026-09-01 Revenue $9.76B beat, adj EPS $1.45 beat, raises FY27 profit and revenue outlook2026-09-02 Q1 revenue and EPS beat, FY27 guidance raised, analysts follow2026-09-04 Strongest revenue growth in a decade, driven by cardiovascular business2026-09-01 → 09-03 Capital Bull
Medtronic Expands Surgical Robotics Access via Cornerstone Robotics Partnership Partnership advances global surgical robotics footprint, strengthening minimally invasive surgery competitiveness
D1 +1.5% · +5d -0.2%
› 3 waves of this story2026-09-01 Bolsters surgical robotics and heart valve innovation, strengthening growth platforms2026-09-02 After investment, strategic partnership aims to increase global access2026-09-03 Partnership advances global surgical robotics footprint, strengthening minimally invasive surgery competitiveness2026-09-01 8-K filing
8-K: Item 2.02, Item 9.01 D1 +1.5% · +5d -0.2%
2026-09-01 Earnings
Earnings report D1 +1.5% · +5d -0.2%
2026-08-20 Company
Medtronic declares $0.72 per share cash dividend for Q2 FY2027 Board approves quarterly dividend, continuing shareholder return policy
D1 -1.9% · +5d -2.5%
2026-08-18 Earnings
Earnings report D1 +1.6% · +5d -1.0%
2026-08-06 Product Bull
Medtronic Expands CE Mark for Affera System to Ventricular Arrhythmias Additional independent source confirms the CE Mark expansion, reinforcing the product milestone
D1 -0.1% · +5d +5.4%
› 2 waves of this story2026-08-06 Sphere-9 first to get CE mark for ventricular ablation, offering new minimally invasive option2026-08-06 Additional independent source confirms the CE Mark expansion, reinforcing the product milestone2026-07-28 Analyst
UBS upgrades to Buy D1 +3.2% · +5d -0.8%
2026-07-21 Capital Bear
Swedish Pension Fund Trims Medtronic Stake by 3.9% in Q1 Institutional stake reduction signals portfolio rebalancing, though modest
D1 -1.1% · +5d +5.5%
2026-07-21 Product Bull
Medtronic to Unveil AI Surgical Platform Touch Surgery Aide FDA-cleared real-time AI on NVIDIA infrastructure marks new era in surgery
D1 -1.1% · +5d +5.5%
2026-07-20 Capital Bull
Decker Wealth Opens $5.08M Position in Medtronic in Q1 13F filing reveals new institutional stake, indicating fund flow
D1 +0.1% · +5d +1.1%
2026-07-20 Earnings
Medtronic to Report Q1 FY2027 Results on September 1 Company sets official date for Q1 FY2027 earnings release
D1 +0.1% · +5d +1.1%
2026-07-16 Capital Bull
Medtronic completes SPR acquisition, expanding pain therapy portfolio Adds category-defining SPRINT PNS technology to broadest pain therapy portfolio
D1 +3.8% · +5d -1.9%
by direction · sourced
Cases AI-clustered from trusted X authors over 2 weeks; counts are distinct authors. Volume does not predict direction · Not investment advice
be the first
🙂 Post
Facts and opinions separated · All items sourced · Not investment advice
